Skip to main content
. 2019 Aug;81(3):351–358. doi: 10.18999/nagjms.81.3.351

Table 3.

Chemotherapy regimen

Adenocarcinoma (n = 3) Non-adenocarcinoma (n = 4)
CDDP weekly CDDP weekly
CDDP+5-FU CDDP weekly
CBCDA+PTX CDDP+5-FU
NDP+5-FU

CDDP: cisplatin

CDDP+5-FU: cisplatin plus 5-fluorouracil

CBCDA+PTX: carboplatin plus paclitaxel

NDP+5-FU: nedaplatin plus 5-fluorouracil.